Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,843 across all filing types
Latest filing 2013-10-16 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
重大事项停牌进展公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (普洛药业股份有限公司) regarding the continuation of a trading suspension due to ongoing major matters under planning. It mentions the stock code, the date of suspension, and the intention to disclose relevant information once determined. There is no financial data, no detailed report, no voting results, no management changes, or other specific report content. The document is brief (383 characters) and serves as a regulatory announcement about trading status. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2013-10-16 Chinese
2013年三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the third quarter of 2013, providing estimated net profit and earnings per share for the period from January 1 to September 30, 2013, and for the third quarter specifically. It explicitly states that the forecast is unaudited and that the final financial data will be in the 2013 third quarter report. The document is short (1568 characters) and serves as a preliminary earnings forecast rather than a full financial report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. 9M 2013
2013-10-14 Chinese
重大事项停牌公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the suspension of trading (停牌公告) of the company's stock due to the planning of a major matter with uncertainty. It is a regulatory announcement related to stock trading status and does not contain financial data, management changes, or detailed report content. The document length is only 387 characters, indicating it is a brief notice. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories like capital changes or delisting.
2013-10-09 Chinese
关于大股东所持股权解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a short announcement regarding the release of pledged shares by a major shareholder. It includes specific details about shareholding and pledge status but does not contain financial statements or detailed financial data. The document length is only 443 characters, indicating it is a brief announcement rather than a full report. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or related shareholding status changes such as pledge releases.
2013-09-16 Chinese
独立董事关于新增日常关联交易事项的独立意见
Board/Management Information Classification · 90% confidence The document is an independent directors' opinion on a new related-party transaction matter discussed at a board meeting. It references compliance with governance guidelines and the company's articles of association, and it provides an independent judgment on the fairness and legality of the transaction. There is no financial data, no report publication, no voting results, no management changes, and no earnings or audit information. This type of document is related to governance and board oversight on transactions, fitting best under Board/Management Information (MANG) as it concerns board-level decisions and opinions on company matters.
2013-08-19 Chinese
2013年新增日常关联交易的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 普洛药业股份有限公司 regarding new daily related-party transactions in 2013. It details the nature of the transactions, parties involved, pricing policies, and impact on the company. The document is short (1221 characters) and focuses on disclosure of related-party transactions rather than financial results or management changes. It does not contain financial statements or detailed financial analysis. This type of announcement fits best under Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other specific categories.
2013-08-19 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.